Keefe, Bruyette & Woods Raises Bowhead Specialty (NYSE:BOW) Price Target to $45.00

Bowhead Specialty (NYSE:BOWGet Free Report) had its price objective increased by Keefe, Bruyette & Woods from $43.00 to $45.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ price target suggests a potential upside of 13.58% from the stock’s previous close.

Several other brokerages have also recently commented on BOW. JPMorgan Chase & Co. lifted their price target on shares of Bowhead Specialty from $30.00 to $35.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 8th. Piper Sandler initiated coverage on shares of Bowhead Specialty in a report on Wednesday, April 16th. They set an “overweight” rating and a $44.00 target price for the company. Finally, JMP Securities increased their price target on Bowhead Specialty from $38.00 to $40.00 and gave the company a “market outperform” rating in a research note on Friday, April 11th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $37.50.

Check Out Our Latest Stock Report on BOW

Bowhead Specialty Stock Performance

NYSE BOW opened at $39.62 on Friday. The stock has a market capitalization of $1.29 billion and a P/E ratio of 30.24. Bowhead Specialty has a 52 week low of $22.14 and a 52 week high of $42.29. The stock has a fifty day moving average of $38.71 and a 200-day moving average of $35.25.

Bowhead Specialty (NYSE:BOWGet Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.01. The firm had revenue of $174.85 million during the quarter, compared to the consensus estimate of $105.17 million. Equities research analysts forecast that Bowhead Specialty will post 1.36 earnings per share for the current fiscal year.

Insider Activity at Bowhead Specialty

In related news, Director Ava Schnidman bought 1,493 shares of Bowhead Specialty stock in a transaction that occurred on Friday, February 28th. The stock was purchased at an average cost of $33.41 per share, with a total value of $49,881.13. Following the purchase, the director now owns 1,893 shares in the company, valued at approximately $63,245.13. This trade represents a 373.25 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Barclays PLC acquired a new position in Bowhead Specialty during the 3rd quarter worth approximately $479,000. JPMorgan Chase & Co. bought a new stake in shares of Bowhead Specialty in the third quarter worth $1,382,000. SG Americas Securities LLC acquired a new position in Bowhead Specialty during the fourth quarter worth $344,000. Rhumbline Advisers grew its position in Bowhead Specialty by 89.5% in the fourth quarter. Rhumbline Advisers now owns 12,601 shares of the company’s stock valued at $448,000 after purchasing an additional 5,953 shares in the last quarter. Finally, Peregrine Capital Management LLC increased its stake in Bowhead Specialty by 143.3% in the 4th quarter. Peregrine Capital Management LLC now owns 295,723 shares of the company’s stock valued at $10,504,000 after buying an additional 174,172 shares during the last quarter.

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Featured Articles

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.